Lucid Diagnostics (LUCD) Retained Earnings (2020 - 2026)
Lucid Diagnostics (LUCD) reported Retained Earnings of -$298.0 million for Q1 2026, down 24.26% on a YoY basis from -$393.4 million in Q1 2025, and down 8.61% quarter-over-quarter from -$274.3 million in Q4 2025.
Lucid Diagnostics (LUCD) Retained Earnings (2020 - 2026) Analysis & Trends
Lucid Diagnostics has reported Retained Earnings for 7 years, with the latest figure at -$298.0 million in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 24.26% year-over-year to -$298.0 million; the trailing twelve-month figure through Mar 2026 stood at -$298.0 million (down 24.26% YoY), and the FY2025 full-year result was -$274.3 million, down 34.63% from the prior year.
- Retained Earnings for Q1 2026 stood at -$298.0 million, down from -$274.3 million in the prior quarter.
- The five-year high for Retained Earnings was -$54.2 million in Q1 2022, with the low at -$298.0 million in Q1 2026.
- Historically, Retained Earnings has averaged -$170.4 million across 5 years, with a median of -$168.8 million in 2024.
- Annual changes were most pronounced in 2022 — Retained Earnings sank 171.74% — and 2026, when it dropped 24.26%.
- Lucid Diagnostics' Retained Earnings stood at -$98.1 million in 2022, then plunged by 53.7% to -$150.7 million in 2023, then plunged by 35.18% to -$203.8 million in 2024, then tumbled by 34.63% to -$274.3 million in 2025, then fell by 8.61% to -$298.0 million in 2026.
- The last three Retained Earnings figures came in at -$298.0 million (Q1 2026), -$274.3 million (Q4 2025), and -$258.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 49.96 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -583.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 32.30 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -398.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -221.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 106.20 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 5.65 Bn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -113.10 Mn |
| 10 | Lucid Diagnostics | 149.20 Mn | 121.33 Mn | -325,000.00 | -297.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -297.96 Mn |
| Dec 31, 2025 | -274.34 Mn |
| Sep 30, 2025 | -258.07 Mn |
| Jun 30, 2025 | -247.67 Mn |
| Mar 31, 2025 | -239.78 Mn |
| Dec 31, 2024 | -203.77 Mn |
| Sep 30, 2024 | -192.23 Mn |
| Jun 30, 2024 | -179.85 Mn |
| Mar 31, 2024 | -168.85 Mn |
| Dec 31, 2023 | -150.74 Mn |
| Sep 30, 2023 | -139.91 Mn |
| Jun 30, 2023 | -125.70 Mn |
| Mar 31, 2023 | -114.32 Mn |
| Dec 31, 2022 | -98.08 Mn |
| Sep 30, 2022 | -83.15 Mn |
| Jun 30, 2022 | -68.80 Mn |
| Mar 31, 2022 | -54.17 Mn |
| Dec 31, 2021 | -41.90 Mn |
| Sep 30, 2021 | -30.60 Mn |
| Dec 31, 2020 | -13.83 Mn |